Author:
Ohi Kazutaka,Takai Kentaro,Kuramitsu Ayumi,Sugiyama Shunsuke,Shioiri Toshiki
Funder
Dainippon Sumitomo Pharma
Subject
Biological Psychiatry,Pharmacology
Reference23 articles.
1. Blonanserin: a review of its use in the management of schizophrenia;Deeks;CNS Drugs,2010
2. Clinical assessment of weight gain with atypical antipsychotics - blonanserin vs amisulpride;Deepak;J. Clin. Diagn. Res. JCDR,2015
3. Anticholinergics in the era of atypical antipsychotics: short-term or long-term treatment?;Desmarais;J. Psychopharmacol. (Oxford, England),2012
4. The efficacy and safety of blonanserin compared with haloperidol in acute-phase schizophrenia: a randomized, double-blind, placebo-controlled, multicentre study;Garcia;CNS Drugs,2009
5. Blonanserin versus haloperidol in Japanese patients with schizophrenia: a phase 3, 8-week, double-blind, multicenter, randomized controlled study;Harvey;Neuropsychopharmacol. Rep.,2019